Nephrocare Health Services bulk deals, insider trading and stake changes
NSE: NEPHROPLUSBSE: 544647Healthcare ServicesSmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹602.40.
- Next results date: the board meets on 3 Nov 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹5,998 Cr739th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- No full year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 19 May 2026
- 5.4
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in Dec 2025
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 19 May 2026
- 0.07
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,48,08043.1% delivered
Promoter and insider buying and selling
Trades made since 23 Oct 2025.Nephrocare Health Services promoter holding
No promoter, director, key manager or employee bought or sold on the market.
- Promoters and promoter group: no market trade
- Others: no market trade · 3 pledge filings of unclear kind
Nephrocare Health Services insider trading
All 23 disclosures on record.Insider trading, all companies
Sep 2026
- Hemant Sultania₹0.46 Cr7,000 sharesPledge · Designated Person · 29 Sep 2026 · disclosed 7 Oct
- Prashant Vinodkumar Goenka₹3.26 Cr46,184 sharesSold or invoked · Designated Person · 24 Sep 2026 · disclosed 5 Oct
- Bessemer Venture Partners Trust₹42 Cr5,98,615 sharesSold or invoked · Promoter · 24 Sep 2026 · disclosed 5 Oct
- Healthcare Parent Limited₹64 Cr9,05,614 sharesSold or invoked · Promoter · 24 Sep 2026 · disclosed 5 Oct
- Sukaran Singh Saluja₹4.94 Cr70,000 sharesSold or invoked · Designated Person · 24 Sep 2026 · disclosed 5 Oct
- Edoras Investment Holdings Pte.Ltd₹119 Cr16,84,218 sharesSold or invoked · Promoter · 24 Sep 2026 · disclosed 5 Oct
- Hemant Sultania₹0.50 Cr7,000 sharesBought · Designated Person · 24 Sep 2026 · disclosed 5 Oct
- Vikram Vuppala₹26 Cr3,66,035 sharesSold or invoked · Designated Person · 24 Sep 2026 · disclosed 5 Oct
- Investcorp Private Equity Fund II₹59 Cr8,29,307 sharesSold or invoked · Promoter · 24 Sep 2026 · disclosed 5 Oct
- Rohit Singh₹4.23 Cr60,000 sharesSold or invoked · Designated Person · 24 Sep 2026 · disclosed 5 Oct
- Viraaj Family Trust₹33 Cr4,70,616 sharesSold or invoked · Promoter · 24 Sep 2026 · disclosed 5 Oct
- Manvi Family Trust₹33 Cr4,70,616 sharesSold or invoked · Promoter · 24 Sep 2026 · disclosed 5 Oct
- Quadria Capital Fund III Holdings Pte. Ltd₹7.87 Cr1,11,628 sharesSold or invoked · Promoter · 24 Sep 2026 · disclosed 5 Oct
- Gadela Dinakar₹0.21 Cr2,709 sharesSold or invoked · Designated Person · 11 Sep 2026 · disclosed 30 Sep
- Jayesh Thakur₹0.18 Cr2,453 sharesSold or invoked · Designated Person · 1 Sep 2026 · disclosed 30 Sep
- Akshay Agarwal₹0.18 Cr2,450 sharesSold or invoked · Designated Person · 1 Sep 2026 · disclosed 30 Sep
Aug 2026
- Moulik₹0.12 Cr1,713 sharesBought · Designated Person · 25 Aug 2026 · disclosed 30 Sep
- Moulik₹0.12 Cr1,713 sharesSold or invoked · Designated Person · 25 Aug 2026 · disclosed 30 Sep
- Nishant Kumar Singh₹0.23 Cr3,375 sharesBought · Designated Person · 3 Aug 2026 · disclosed 30 Sep
- Nikhil Srivastava₹0.26 Cr3,750 sharesBought · Designated Person · 3 Aug 2026 · disclosed 30 Sep
Feb 2026
- Mootha Satish₹0.06 Cr1,000 sharesSold or invoked · Designated Person · 3 Feb 2026 · disclosed 7 Apr
- Mootha Satish₹0.02 Cr480 sharesPledge · Designated Person · 3 Feb 2026 · disclosed 7 Apr
- Mootha Satish₹0.05 Cr960 sharesPledge · Designated Person · 3 Feb 2026 · disclosed 7 Apr
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Nephrocare Health Services stake sales and purchases
All 3 disclosures on record.
Dec 2025
- AcquiredPolar Capital Funds PLC - Healthcare Opportunities Fund0.21% of the company2,12,230 sharesholds 5.04% after19 Dec 2025 · filed under the 5% rule · Open Market
- AcquiredPolar Capital Funds PLC - Healthcare Discovery Fund1,684 sharesholds 6,028 shares after19 Dec 2025 · filed under the 5% rule · Open Market
- AcquiredPolar Capital Funds PLC - Emerging Markets Healthcare Fund417 sharesholds 9,240 shares after19 Dec 2025 · filed under the 5% rule · Open Market
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Nephrocare Health Services bulk deals
Last 12 months, since 23 Oct 2025: 13 bulk deals, ₹489 Cr bought and ₹254 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Thursday 24 Sep 20263 firms · ₹238 Cr bought · ₹177 Cr soldNet bought ₹60 Cr
- BoughtPOLAR CAPITAL FUNDS PLC-HEALTHCARE OPPORTUNITIES FUNDBought 25,45,719 at ₹705.002.54% of the company₹179 Cr
- SoldEDORAS INVESTMENT HOLDINGS PTE LTDSold 16,84,218 at ₹707.611.68% of the company₹119 Cr
- Both waysMANSI SHARE AND STOCK BROKING PRIVATE LIMITEDBought 8,23,311 at ₹705.24Sold 8,15,776 at ₹710.450.82% of the companyNet +7,535 shares₹58 Cr bought
Wednesday 17 Dec 20255 firms · ₹251 Cr bought · ₹76 Cr soldNet bought ₹175 Cr
- BoughtPOLAR CAPITAL FUNDS PLC-HEALTHCARE OPPORTUNITIES FUNDBought 34,27,866 at ₹481.773.42% of the company₹165 Cr
- BoughtPOONAWALLA VISION FUND IBought 6,10,000 at ₹490.050.61% of the company₹30 Cr
- Both waysRAJASTHAN GLOBAL SECURITIES PVT LTDBought 50,000 at ₹491.00Sold 5,20,381 at ₹490.100.52% of the companyNet −4,70,381 shares₹2.46 Cr bought
- Both waysMARWADI CHANDARANA INTERMEDIARIES BROKERS PRIVATE LIMITEDBought 5,33,995 at ₹482.75Sold 4,88,995 at ₹477.650.53% of the companyNet +45,000 shares₹26 Cr bought
- Both waysMANSI SHARE AND STOCK BROKING PRIVATE LIMITEDBought 5,70,020 at ₹490.00Sold 5,70,020 at ₹483.300.57% of the companyNet nil₹28 Cr bought
A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 13 deals on record since listing on 17 Dec 2025.